As the market for GLP-1 injections continues to grow, BD aims to ride that wave by providing drugmakers with its prefilled syringes. Biologic medications—including those blockbusters for diabetes and ...
FRANKLIN LAKES, N.J. and SAN DIEGO, Jan. 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of laboratory ...
Yesterday, Becton, Dickinson and Company BDX, popularly known as BD, announced a collaboration with ChemoGLO, a notable name in hazardous drug detection and decontamination. The partnership is aimed ...
FRANKLIN LAKES, N.J., Sept. 22, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a pharmacy automation partnership with ...
Becton, Dickinson and Co. plans to invest more than $35 million to expand a prefilled flush syringe manufacturing facility in Nebraska to better meet growing demand from U.S. hospitals and health care ...
The global medical technology company will create 50 new jobs at its Columbus facility, increasing the resiliency of the U.S. healthcare system. BD, a leading global medical technology company, will ...
FRANKLIN LAKES, N.J., Dec. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global medical technology company, and ChemoGLO™, a specialist in hazardous drug detection and ...
Explore the role of BD&L in R&D decision-making. Understand its impact on funding and market intelligence for scientists.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results